Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

This study tests an experimental drug called YD0743 in adults with sepsis who have developed severe lung failure (ARDS) and need a breathing machine. The main goal is to see if the drug can shorten the time patients need a ventilator. About 309 ICU patients will receive either YD…

This study tests an experimental tablet called HTMC0658 in 30 adults with chronic sinusitis (without nasal polyps). The goal is to see if the drug can reduce sinus inflammation and improve symptoms like congestion and facial pain. Participants will take the tablet for 12 weeks an…

This study tests an experimental tablet called HL-1186 for moderate to severe pain after surgery. About 72 adults having orthopedic, abdominal, or chest surgery will receive either the drug or a placebo. The main goal is to see if the drug reduces pain over 48 hours and to check …

This study tests a new tablet called HL-1186 to see if it safely reduces moderate to severe pain after abdominal surgery. About 40 adults will receive either the drug or a placebo. The main goal is to measure pain relief over 48 hours using a standard pain scale.